Regional Cancer Statistics: Upcoming Release of Local Prevalence Data

A new, groundbreaking registry is set to provide the public with up-to-date information about the most prevalent cancers in various regions. This initiative aims to increase transparency and awareness of local cancer trends for residents and health professionals alike.

A Transformative Step in Cancer Surveillance

In the fight against cancer, France is now charting new territory. With nearly 3.8 million adults living with a previous diagnosis and more than 433,000 fresh cases recorded in 2023 alone, the disease’s reach continues to grow, according to the latest figures from the Institut national du cancer (INC). Responding to this mounting health challenge, French lawmakers passed legislation on June 30, 2025, that entrusts the INC with establishing a truly comprehensive national cancer registry. But what exactly does this ambitious project entail?

The Ambition: Comprehensive and Reliable Data

Until now, cancer tracking in France has relied heavily on fragmented local registries, covering only a fraction of the adult population and limited tumor sites. This new nationwide effort seeks to fill those gaps by systematically recording every case across all regions. As explained by Claire Morgand, head of observation and data at the INC, this project aims to build a “health data warehouse” from both medical and administrative records related to patients currently or previously affected by cancer. Such an infrastructure could dramatically reshape epidemiological research and public health policy.

Protecting Privacy While Advancing Research

Of course, consolidating sensitive patient data at this scale inevitably raises privacy concerns. The collection process—already involving information from some 13.6 million individuals—remains strictly regulated under medical confidentiality laws. Only authorized researchers can access these anonymized datasets, with clear objectives: to deepen understanding of regional cancer patterns, refine treatment pathways, and better target preventive strategies.

Several factors explain how this data repository will be built:

• Hospital and clinical sources;
• Medico-administrative databases;
• Health insurance systems alongside existing registries.

A Future-Oriented Approach to Care and Prevention

For Didier Lepelletier, Director General of Health, this registry represents far more than a statistical exercise. He describes it as “a reliable, secure framework for expanding knowledge—while also improving prevention and long-term follow-up for oncology patients.” As data continues to accumulate over time, experts anticipate an ever-finer map of cancer’s impact throughout France. Ultimately, both researchers and public health authorities hope such insights will enable them not only to treat but also to understand—and perhaps one day outpace—this complex disease in all its regional and human diversity.